OPTN logo

OptiNose (OPTN)

Profile

Full Name

OptiNose, Inc.

Ticker Symbol

OPTN

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

October 13, 2017

Indexes

Not included

Website

http://www.optinose.com

Employees

127

Key Details

Price

$9.17(+0.11%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$78.23M(+10.20% YoY)

Annual EPS

-$2.12(+55.37% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$9.17
OPTN price is $9.17

30-Day Relative Volume

0.61
OPTN 30-day relative volume is 0.61

Price Performance

Price Today change

+0.11%
OPTN price is up +0.11% today

Price YTD change

+37.28%
OPTN price is up +37.28% since January 1st

Price 1-year change

-40.07%
OPTN price is down -40.07% year-on-year

Price 3-year change

-75.93%
OPTN price is down -75.93% over the past 3 years

Price Range

Price All-time high

$446.40
OPTN price is currently -97.95% below its historical high of $446.40

Price 3-year low

$0.32
OPTN price is currently +2756.70% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$92.84M
OPTN market capitalization is $92.84 million

Market cap 3-year change

-55.79%
OPTN market capitalization is down -55.79% over the past 3 years

Market cap All-time high

$1.22B
OPTN market capitalization is currently -92.41% below its historical high of $1.22 billion

Market cap sector rank

47.78%
OPTN market capitalization is higher than 47.78% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+34.35%
OPTN shares outstanding is up +34.35% year-on-year

Shares Outstanding 3-Year Change

+83.67%
OPTN shares outstanding is up +83.67% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.54
OPTN beta is 0.54

200-day SMA

$9.91
OPTN price is currently -7.48% below its 200-day simple moving average

50-day SMA

$7.04
OPTN price is currently +30.24% above its 50-day simple moving average

RSI

76.60
OPTN 14-day relative strength index is 76.60

Volume

0.61
OPTN 30-day relative volume is 0.61

ATR

$0.23
OPTN average true range is $0.23

10-day Historical Volatility

8.21%
OPTN 10-day historical volatility is 8.21%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$78.23M
OPTN annual revenue is $78.23 million

Revenue Analysts estimate

$118.20M
OPTN annual revenue is currently -33.82% lower than the consensus analysts' forecast

Revenue 1-year change

+10.2%
OPTN annual revenue is up +10.2% year-on-year

Revenue Sector rank

52.97%
OPTN annual revenue is higher than 52.97% of companies in Healthcare sector

EPS

EPS

-$2.12
OPTN annual earnings per share is -$2.12

EPS Analysts estimate

-$1.03
OPTN annual earnings per share is currently +105.83% higher than the consensus analysts' forecast

EPS 1-year change

+55.37%
OPTN annual earnings per share is up +55.37% year-on-year

EPS Sector rank

37.6%
OPTN annual earnings per share is higher than 37.6% of companies in Healthcare sector

Profit

Gross profit

$71.00M
OPTN annual gross profit is $71.00 million

Gross margin

90.76%
OPTN annual gross profit margin is 90.76%

Operating profit

-$16.32M
OPTN annual operating income is -$16.32 million

Operating margin

-20.86%
OPTN annual operating profit margin is -20.86%

Net income

-$21.54M
OPTN annual net profit is -$21.54 million

Net margin

-27.54%
OPTN annual net profit margin is -27.54%

Expenses

Total expenses

$94.55M
OPTN annual total expenses is $94.55 million

Operating expenses

$87.31M
OPTN annual total operating expenses is $87.31 million

Cost of goods sold

$7.23M
OPTN annual cost of goods sold is $7.23 million

Selling, general & administrative expenses

$83.46M
OPTN annual SGA is $83.46 million

Depreciation and amortization

$283.00K
OPTN annual depreciation & amortization is $283.00 thousand

Interest expense

$20.06M
OPTN annual interest expense is $20.06 million

Income tax

-
OPTN annual income tax value is unknown

EBIT & EBITDA

EBIT

-$1.48M
OPTN annual earnings before interest & taxes is -$1.48 million

EBITDA

-$1.20M
OPTN annual EBITDA is -$1.20 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$128.78M
OPTN annual total assets is $128.78 million

Non current assets

$2.94M
OPTN annual long term assets is $2.94 million

Current assets

$125.84M
OPTN annual total current assets is $125.84 million

Cash and cash equivalents

$84.48M
OPTN annual cash & cash equivalents is $84.48 million

Accounts receivable

$26.39M
OPTN annual accounts receivable is $26.39 million

Inventory

$11.46M
OPTN annual inventory is $11.46 million

Liabilities

Total liabilities

$169.15M
OPTN annual total liabilities is $169.15 million

Long term liabilities

$6.33M
OPTN annual total long term liabilities is $6.33 million

Current liabilities

$162.81M
OPTN annual total current liabilities is $162.81 million

Accounts payable

$450.00K
OPTN annual accounts payable is $450.00 thousand

Debt

Total debt

$128.96M
OPTN annual total debt is $128.96 million

Total debt 1-year change

-2.12%
OPTN annual total debt is down -2.12% year-on-year

Long term debt

$1.23M
OPTN annual long term debt is $1.23 million

Short term debt

$127.73M
OPTN annual short term debt is $127.73 million

Equity & Capital

Shareholders equity

-$40.36M
OPTN annual stockholders equity is -$40.36 million

Book value

-$40.36M
OPTN annual book value is -$40.36 million

Retained earnings

-$741.92M
OPTN annual retained earnings is -$741.92 million

Working capital

-$36.97M
OPTN annual working capital is -$36.97 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$44.68M
OPTN annual cash flow from operations is -$44.68 million

Cash from operations 1-year change

-117.61%
OPTN annual cash flow from operations is down -117.61% year-on-year

Cash from investing

-$72.00K
OPTN annual cash flow from investing activities is -$72.00 thousand

Cash from investing 1-year change

+78.05%
OPTN annual cash flow from investing activities is up +78.05% year-on-year

Cash from financing

$55.55M
OPTN annual cash flow from financing activities is $55.55 million

Cash from financing 1-year change

+18417.67%
OPTN annual cash flow from financing activities is up +18417.67% year-on-year

CAPEX

CAPEX

$72.00K
OPTN annual capital expenditures is $72.00 thousand

CAPEX 1-year change

-78.05%
OPTN annual capital expenditures is down -78.05% year-on-year

Free Cash Flow

Free cash flow

-$44.75M
OPTN annual free cash flow is -$44.75 million

Free cash flow 1-year change

-114.53%
OPTN annual free cash flow is down -114.53% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

90.76%
OPTN annual gross profit margin is 90.76%

Operating margin

-20.86%
OPTN annual operating profit margin is -20.86%

Net margin

-27.54%
OPTN annual net profit margin is -27.54%

ROA & ROE

ROA

-18.22%
OPTN annual return on assets is -18.22%

ROE

53.37%
OPTN annual return on equity is 53.37%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OPTN price to earnings ratio value is unknown

PE ratio Sector rank

-
OPTN price to earnings ratio is unknown

PB Ratio

PB ratio

-2.30
OPTN price to book ratio is -2.30

PB ratio Sector rank

5.85%
OPTN price to book ratio is higher than 5.85% of companies in Healthcare sector

PS Ratio

PS ratio

1.19
OPTN price to sales ratio is 1.19

PS ratio Sector rank

31.03%
OPTN price to sales ratio is higher than 31.03% of companies in Healthcare sector

Enterprise value

Enterprise value

$137.32M
OPTN enterprise value is $137.32 million

Enterprise value Sector rank

53.51%
OPTN enterprise value is higher than 53.51% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-114.53
OPTN EV/EBITDA is -114.53

EV/EBITDA Sector rank

1.04%
OPTN EV/EBITDA is higher than 1.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.77
OPTN annual current ratio is 0.77

Quick ratio

0.70
OPTN annual quick ratio is 0.70

Leverage

Debt to equity

-3.13
OPTN annual debt to equity ratio is -3.13

Interest coverage ratio

-0.07
OPTN annual interest coverage ratio is -0.07

Risk & Stability

Piotroski F-Score

2
OPTN piotroski f-score is 2

Altman Z-Score

-7.51
OPTN altman z-score is -7.51

Analyst ratings

Recent major analysts updates

Mar 21, 25 Piper Sandler
Neutral
Mar 21, 25 HC Wainwright & Co.
Neutral
Mar 20, 25 Lake Street
Hold
Jan 16, 25 Lake Street
Buy
Jan 3, 25 HC Wainwright & Co.
Buy
Nov 13, 24 Piper Sandler
Overweight
Nov 13, 24 HC Wainwright & Co.
Buy
May 15, 24 Lake Street
Buy
May 15, 24 HC Wainwright & Co.
Buy
Apr 29, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

MGRM logo
Monogram Orthopaedics (MGRM)
eXoZymes (EXOZ)
AIRS logo
AirSculpt Technologies (AIRS)
NAUT logo
Nautilus Biotechnology (NAUT)
ZNTL logo
Zentalis Pharmaceuticals (ZNTL)
IMUX logo
Immunic (IMUX)
XBIT logo
XBiotech (XBIT)
Invizyne Technologies (IZTC)
ORMP logo
Oramed Pharmaceuticals (ORMP)
  • What is the ticker symbol for OptiNose?
  • Does OptiNose pay dividends?
  • What sector is OptiNose in?
  • What industry is OptiNose in?
  • What country is OptiNose based in?
  • When did OptiNose go public?
  • Is OptiNose in the S&P 500?
  • Is OptiNose in the NASDAQ 100?
  • Is OptiNose in the Dow Jones?
  • When was OptiNose's last earnings report?
  • When does OptiNose report earnings?
  • Should I buy OptiNose stock now?

What is the ticker symbol for OptiNose?

The ticker symbol for OptiNose is NASDAQ:OPTN

Does OptiNose pay dividends?

No, OptiNose does not pay dividends

What sector is OptiNose in?

OptiNose is in the Healthcare sector

What industry is OptiNose in?

OptiNose is in the Drug Manufacturers - Specialty & Generic industry

What country is OptiNose based in?

OptiNose is headquartered in United States

When did OptiNose go public?

OptiNose's initial public offering (IPO) was on October 13, 2017

Is OptiNose in the S&P 500?

No, OptiNose is not included in the S&P 500 index

Is OptiNose in the NASDAQ 100?

No, OptiNose is not included in the NASDAQ 100 index

Is OptiNose in the Dow Jones?

No, OptiNose is not included in the Dow Jones index

When was OptiNose's last earnings report?

OptiNose's most recent earnings report was on Mar 20, 2025

When does OptiNose report earnings?

The next expected earnings date for OptiNose is May 14, 2025

Should I buy OptiNose stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page